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BACKGROUND AND PURPOSE: Encephaloduroarteriosynangiosis (EDAS) has become the
main treatment for moyamoya disease, a chronically progressive cerebrovascular occlusive
disease in children. We aimed to assess the utility of perfusion-weighted MR imaging for
evaluating hemodynamic changes before and after EDAS.
METHODS: Thirteen patients with angiographically confirmed moyamoya disease who un-
derwent EDAS were investigated, and results were compared with those of a control group (n
5). Perfusion MR imaging was performed before and after EDAS by using a T2*-weighted
contrast material–enhanced technique. Relative cerebral blood volume (rCBV) and time to
peak enhancement (TTP) maps were calculated. Relative ratios of rCBV and TTP in the middle
cerebral artery (MCA) and basal ganglia were measured and compared with those of the
posterior cerebral artery (PCA). Changes in hemodynamic parameters between pre- and
post-EDAS perfusion maps were investigated.
RESULTS: The mean rCBV ratio of MCA to PCA in the patient group was slightly higher
than that in the control group, without statistical significance. All 13 patients showed a delayed
TTP in the MCA before EDAS compared with the control group (P  .0006), and the TTP after
EDAS was significantly reduced (P  .0002). In the basal ganglia, shortening of the TTP was
demonstrated before EDAS, but no significant change was observed after EDAS.
CONCLUSION: Perfusion-weighted MR imaging can be applied for evaluating postoperative
changes in cerebral blood flow in moyamoya disease. Shortening of the TTP in the MCA of the
hemisphere operated on is a marker for the development of collateral circulation from the
external carotid artery to the internal carotid artery.
Moyamoya disease is a chronically progressive cere-
brovascular disease affecting the supraclinoid internal
carotid arteries (ICAs) with prominent collateral ar-
terial formation (1). Despite the fact that moyamoya
disease is thought to affect primarily Japanese or
Koreans, it also has been reported in other ethnic
groups (2, 3). The etiology is still uncertain, and
without proper treatment, children presenting with
ischemic symptoms tend to show an aggravating nat-
ural course (4). Encephaloduroarteriosynangiosis
(EDAS) is the treatment of choice because this pro-
cedure can reestablish cerebral perfusion by means of
external carotid artery (ECA)-to-ICA bypass (5). De-
velopment of collateral vessels after surgery usually
occurs in the middle cerebral artery (MCA) territory
because of the distribution of the superficial temporal
artery, which is the most commonly used supplier for
EDAS. Although other advanced procedures for re-
construction of blood flow to the anterior cerebral
artery (ACA) territory have been introduced recently
(6–8), EDAS is still widely used in many institutes.
Conventional angiography is used to diagnose
moyamoya disease (9), but single photon emission
tomography (SPECT) is known to be the reference
standard for evaluating the hemodynamic status of
patients with moyamoya disease (10, 11). MR imaging
also has been widely used in assessing moyamoya
disease, because of its capacity to illustrate anatomic
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detail and the vascular architecture (12, 13). Re-
cently, T2*-weighted perfusion MR imaging has been
found to be effective in estimating cerebral hemody-
namics in moyamoya disease (14–17). These diagnostic
maneuvers can be used to assess local hemodynamic
changes after ICA-to-ECA bypass surgery (18–20).
However, there is a paucity of reports describing the
efficacy of perfusion-weighted MR imaging in postop-
erative evaluation. The purpose of this study was to
assess the utility of perfusion MR imaging in illustrating
the hemodynamic changes of an ischemic brain in moya-
moya disease before and after EDAS.
Methods
Thirteen patients with childhood moyamoya disease who
underwent EDAS between July 1999 and March 2002 were
evaluated by using perfusion-weighted MR imaging before and
after surgery. The subjects consisted of eight female and five
male patients, with ages ranging from 2 to 27 years (mean, 8.5
years). They received preoperative diagnostic evaluation with
technetium-99m ethyl cysteinate dimer SPECT and conven-
tional angiography. On cerebral angiograms, all 13 patients
showed stenosis, either partial or complete obstruction, in the
supraclinoid portion of the ICAs. All showed patent posterior
cerebral arteries (PCAs) and various degrees of leptomenin-
geal collateral vessels (eg, less than Suzuki grade V [21]).
EDAS was performed according to the patients’ clinical symp-
toms and angiographic findings. EDAS was performed in the
left cerebral hemisphere in four patients, in the right cerebral
hemisphere in three patients, and in both hemispheres in the
remaining six patients.
All patients underwent preoperative perfusion-weighted
MR imaging 3–7 days before EDAS and postoperative perfu-
sion-weighted MR imaging 6–8 months after EDAS. Five
children (three male, two female subjects; mean age, 9.3 years;
age range, ) were included in the control group because healthy
volunteers were not available for perfusion study. Age-matched
control subjects could not be recruited because they would
have needed sedation, and ethical considerations prohibited
this. The control subjects were referred for brain imaging with
the complaint of simple headache or psychiatric problem. They
were found to have no central nervous system disease radio-
logically and at follow-up studies. Informed consent was re-
ceived from all participants or the participants’ parents or legal
guardian, and all procedures were performed under approval
by the institutional board of clinical studies.
The MR examinations were conducted by using a 1.5-T
system (Signa Horizon, GE Medical System, Milwaukee, WI,
or Gyroscan Intera, Philips Medical Systems, Best, the Neth-
erlands) with a quadrature head coil. Perfusion-weighted MR
imaging was performed by using a single-shot gradient-echo
echo-planar imaging sequence during an intravenous bolus
injection of 0.2 mmol/kg gadopentetate dimeglumine (Magne-
vist; Schering AG, Berlin, Germany) with the following param-
eters: 1500/40/1 (TR/TE/excitations), 24-cm field of view, 5-mm
section thickness with a 2-mm intersection gap, and 128  128
matrix. Six sections were chosen starting from the anteropos-
terior commisure line including the transthalamic level, and 40
dynamic perfusion images were obtained from each level. Con-
trast material was injected by using a power injector (Spectris;
Medrad, Indianola, PA) after the fifth dynamic image, followed
by flushing with normal saline, and image acquisition continued
until all 40 phase images were obtained.
Data from the eight patients who were examined with the
GE system were transferred to a personal computer, where the
data were analyzed by using a program coded for Interactive
Data Language (IDL 5.4 Win32; Research Systems Inc., Boul-
der, CO). The data of the other five patients examined with the
Philips system were processed by Easyvision (Philips Medical
Systems). For each pixel, the time-concentration or R2* curve
was obtained, which was calculated from the equation
R2*(t)  [ln(SI0/SI(t))], where SI0 is the average precontrast
signal intensity and SI(t) is the signal intensity at time t. The
relative cerebral blood volume (rCBV) was calculated pixel by
pixel from the time-relaxation curve obtained by dynamic im-
aging. The time interval to peak enhancement (TTP) maps
were also calculated. The regions of interest in the bilateral
MCA territory, PCA territory, and basal ganglia were drawn
(Fig 1) and contained more than 20 pixels. The rCBV ratios
and TTP differences of the MCA and of the basal ganglia to the
PCA territory were calculated on the pre- and postoperative
perfusion MR images. Statistical analysis was done between
patients and control group by using the Student’s t test for the
independent samples. A paired t test was used to analyze the
patient group for changes before and after EDAS. A P value of
less than or equal to .05 was considered to indicate a statisti-
cally significant difference.
Results
The measured rCBV and TTP values in the control
and patient groups are listed in the Table. The mean
rCBV ratio of the MCA to PCA territory in the
control group was 1.35  0.14 in the MCA territory
and 0.79  0.12 in the basal ganglia. The TTP in the
MCA territory was identical to that of the PCA ter-
FIG 1. Regions of interest (MCA, PCA, and BG) are drawn on a
TTP map. On the rCBV maps (not shown), the relative signal
intensity ratios of the MCA and the BG to the PCA territory were
obtained, whereas on the TTP maps the time differences in the
MCA and BG were calculated and compared with that of the
PCA territory.





(n  13) P Value*
rCBV ratio
MCA to PCA 1.35  0.14 1.31  0.66 .950
BG to PCA 0.79  0.12 0.78  0.25 .756
TTP difference (sec)
MCA to PCA 0 4.37  2.25 .0006
BG to PCA 0.76  0.22 1.08  1.99 .765
Note.—Data are the mean  SD.
* Two-tailed t test.
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ritory, whereas the TTP in the basal ganglia was
shorter than that in the PCA territory.
The mean rCBV ratio of MCA to PCA territory
was slightly higher than that in the control group,
without statistical significance (P  .950, t test for
independent samples, two-tailed). In the basal gan-
glia, no definite change in rCBV was observed in the
patient group when compared with the control group
(P  .756). The TTP delay was striking in the MCA
territory of the affected hemisphere in the patient
group, with an average 4.37 seconds delay compared
with the control group (P  .0006). Three of 13
patients showed an asymmetric delay in the TTP in
both MCA territories. This corresponded well with
FIG 2. 9-year-old boy with moyamoya
disease.
A, Anteroposterior angiogram of the
right ICA shows an occlusion of the su-
praclinoid portion, with development of
multiple basal collateral vessels (moya-
moya vessels).
B, Left ICA angiogram depicts mild
changes of the luminal caliber in the left
MCA, but with preserved patency. Left
ACA shows severe narrowing.
C, Technetium-99m ethyl cysteinate
dimer SPECT scan (left scan) reveals de-
creased perfusion in both hemispheres,
more prominent on the right side. After the
acetazolamide (Diamox) injection (right
scan), there is no evidence of a significant
perfusion reduction.
D, Perfusion MR images show delayed
TTP in the right hemisphere before EDAS
(arrows in left TTP map) and a signal in-
tensity reduction after EDAS (arrows in
right TTP map), which means a restoration
of rapid flow at the surgical site. Note,
rCBV maps show nothing significant.
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conventional angiography, which depicted a different
degree of stenosis between both MCAs (Fig 2). In the
basal ganglia, no significant TTP differences could be
found between the two groups.
After surgery, the rCBV ratio in the MCA territory
decreased in the case of the initial rCBV increase, but
the overall change in the rCBV value was not statis-
tically significant (P  .281, paired t test, two-tailed)
(Fig 3A). The rCBV in the basal ganglia also did not
depict any changes after surgery (Fig 3B). The TTP in
the MCA territory operated on was significantly
shortened after surgery (P .0002), whereas the TTP
in the basal ganglia was not (Fig 4). TTP shortening
was demonstrated as a marked signal intensity reduc-
tion in the calculated maps after EDAS (Fig 2D).
One patient underwent additional postoperative per-
fusion MR imaging before a second surgery on the
contralateral side. The second perfusion MR imaging
examination was performed 1 month after EDAS on
the left side, and the patient then underwent a right
EDAS. On the second perfusion MR image, the TTP
shortening of the operated hemisphere was not defi-
nite, which suggested that neovascularization was not
established at that time. Six months later, the patient
was again evaluated with perfusion MR imaging and
conventional angiography. On the follow-up conven-
tional angiogram, neovascularization and prominent
vascular staining were demonstrated from the ECA to
the frontoparietal cerebral cortex. The results agreed
well with those of perfusion MR imaging, which de-
picted shortened TTP at the left MCA territory after
surgery (Fig 5).
Discussion
As moyamoya disease forms many collateral vessels
owing to the occlusion of major proximal intracranial
arteries, the key role of imaging diagnosis has been
focused on detecting collateral circulation, although
the disease may induce an infarct or hemorrhage. CT
was found to be useful in detecting the important
diagnostic signs such as arterial occlusions and the
formation of collateral vessels (22). However, a defi-
nite diagnosis is made with conventional angiography
(9), which can depict the characteristic basal collat-
eral vessels resembling a “puff of smoke” (ie, moya-
moya vessels). Conventional angiography provides a
detailed status of collateral development and stenosis
of major cerebral arteries. In children, the moyamoya
vessels change through six stages: 1) carotid fork
stenosis; 2) progressive carotid stenosis with initial
moyamoya collateral vessels and dilatations of cere-
bral arteries; 3) dilatation of moyamoya collateral
vessels and disappearance of ACAs and MCAs; 4)
thinning of moyamoya vessels; 5) contraction of
moyamoya vessels and disappearance of PCAs; and
6) intracerebral vessels perfused from the ECA
and/or vertebrae. On the basis of this grading system,
the moyamoya vessels of all patients in this study were
below grade 5. MR angiography has also played a role
in detecting the collateral arteries, although many
institutes prefer conventional angiography as a pri-
mary diagnostic tool.
Alterations in the local cerebral hemodynamic sta-
tus are more important in understanding and plan-
FIG 3. A and B, Graphs show changes in the rCBV ratios to the
posterior circulation of the MCA territory (A) and the basal gan-
glia (B). The rCBV can be increased or decreased before (Preop)
and after (Postop) surgery, which cannot characterize the rCBV
patterns of moyamoya disease.
FIG 4. A and B, Graphs show changes in the TTP delay to the
posterior circulation of the MCA territory (A) and basal ganglia
(B). Note the markedly increased TTP in the MCA territory, with
a significant reduction after surgery (Postop). There were no
specific changes in the TTP values in the basal ganglia.
744 LEE AJNR: 24, April 2003
ning treatments for patients with moyamoya disease,
which cannot be assessed with angiography alone.
Scintigraphic methods, such as SPECT or positron
emission tomography, are the reference standard for
assessing cerebral hemodynamics because the tracer
decay kinetics are well known, and the tracer distri-
bution is proportional to the local cerebral blood
flow. Previous studies have reported reduced regional
cerebral blood flow in the frontal and temporal lobes
and increased flow in the parietal and occipital lobes
FIG 5. 7-year-old boy with moyamoya
disease.
A, Preoperative left carotid angiogram
shows an occlusion of the supraclinoid ICA
with basal collateral vessels. No transdural
collateral vessels from the superficial tem-
poral or middle meningeal arteries are seen.
B, Vertebral artery angiogram shows
prominent leptomeningeal collateral ves-
sels supplying the bilateral hemispheres.
C, Serial perfusion-weighted MR im-
ages (rCBV, top row; TTP, bottom row)
were obtained because the patient under-
went bilateral EDAS procedures with a
1-month interval. One-month follow-up per-
fusion MR image shows a mild reduction in
the TTP delay (arrow in middle TTP map),
which means neovascularization is begin-
ning to develop. The last perfusion MR im-
age (right TTP map) shows near-complete
normalization of the TTP in the left hemi-
sphere (solid arrow) and a partial TTP short-
ening on the right side (open arrow).
D and E, Postoperative 7-month fol-
low-up left ECA angiograms show suc-
cessful neovascularization from the mid-
dle meningeal and superficial temporal
arteries.
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and the basal ganglia (10, 23). These flow changes
reflect the course of the disease, which starts from the
ICA, MCA, and extends to the PCA. The posterior
circulation usually supplies the ischemic frontotem-
poral lobes via the leptomeningeal collateral vessels,
whereas the deep nuclei are supplied from the mul-
tiple basal collateral vessels. Such findings can be
detected with perfusion-weighted echo-planar MR
imaging. Yamada et al (17) demonstrated a reduced
rCBV and a TTP delay at the anterior circulation in
the case of a stenotic PCA. In contrast, the current
study showed a TTP delay in all patients, even those
with a normal PCA, whereas the rCBV changes var-
ied. Angiography showed normal calibers of the
PCAs and prominent leptomeningeal collateral ves-
sels in all subjects. An asymmetric TTP delay between
both MCA territories was also observed in three of 10
patients, in whom a different degree of stenosis was
clearly depicted at conventional angiography. The
TTP delay of the anterior circulation was propor-
tional to the severity of the ICA stenosis. Therefore,
this is a universal finding of moyamoya disease on
perfusion MR images and can reflect the severity of
the disease.
The goal of surgical treatment in moyamoya dis-
ease is to reestablish cerebral blood flow to the isch-
emic regions. EDAS is widely used in childhood
moyamoya disease because it is a simple procedure
and has a low risk of ischemia during temporary
blocking of the cerebral blood flow in a conventional
superficial temporal artery–MCA anastomosis (4,
24). Most surgical procedures have focused on in-
creasing the blood flow primarily in the MCA terri-
tory and do not directly benefit the ACA territory (8).
We measured the perfusion changes of only the MCA
territory because of the nature of the surgical proce-
dure. If a modified procedure that can reestablish the
ACA flow is chosen for investigation, perfusion mea-
surement must be done in the ACA territory in the
future.
After EDAS, the superficial temporal artery or the
adjacent middle meningeal artery participates in
forming collateral pathways and can be detected with
conventional angiography (25) or MR angiography
(20). The effectiveness of EDAS must be assessed not
only by visualizing the neovascularization but also by
monitoring improved perfusion status with other di-
agnostic techniques. In this study, an alteration of the
temporal parameters of perfusion-weighted MR im-
aging (eg, delay of TTP in the affected territory and
reduction of TTP delay after surgical treatment,
which corresponded with the rapid staining of cere-
bral arteries from ECA anastomosis) was shown. All
patients who showed a decreased TTP delay in this
study showed a fairly good outcome after surgery.
Therefore, a reduction of the TTP in the MCA ter-
ritory can indirectly reflect the improved perfusion
status, although an accurate interpretation of the TTP
in cerebral hemodynamics is still unclear.
TTP maps or angiography cannot assess perfusion
at the cellular level, because they depict only the
capillary blood flow. A cellular extraction of radio-
tracers can reflect such microhemodynamics, and a
complete evaluation of postoperative patients must
include postoperative scintigraphic studies. Although
our protocol did not include postoperative SPECT,
clinical improvement and angiographic evidence are
enough to support satisfactory cerebral perfusion.
Moreover, as conventional MR imaging can be per-
formed easily during the postoperative period, it can
be used as a primary follow-up diagnostic tool for
evaluating the surgical outcome.
All hemodynamic parameters of perfusion-weighted
imaging were relative values; therefore, the differences
between the MCA and PCA territories could not be
compared. The arterial input function of the MCA ter-
ritory was impossible to obtain because the MCA was
not identified in moyamoya disease. Actually, the real
arterial input function of the cerebrum could not be
assessed owing to the nature of the disease.
Previous studies with perfusion MR imaging or
SPECT used a cerebral-to-cerebellar ratio or region-
to-mean hemispheric blood volume to calculate re-
gional cerebral blood flow (17, 26, 27). In the current
study, the authors compared MCA territorial blood
flow to occipital lobe-PCA territory because all pa-
tients showed patent PCAs at angiography. We could
not use the occipital lobe instead of cerebellum as a
standard because posterior fossa images were poor
with echo planar imaging sequences due to suscepti-
bility artifacts by the skull base and mastoid air cells.
If ECA-to-ICA anastomosis occurs, the cerebral he-
modynamics must be changed, including the mean
hemispheric blood flow and volume. Therefore, the
method in this study of using PCA and its territorial
blood volume as a standard may be more ideal than
the mean hemispheric blood volume in the pre- and
postoperative evaluation with normal PCA flow.
However, it is clear whether one should use another
standard hemodynamic parameter if the patient has a
stenotic or occluded PCA.
Lack of normal control values from healthy volun-
teers is a limitation of this study. We used control
data from patients with simple headache or psychiat-
ric conditions because we could not perform dynamic
bolus injection of MR contrast material in healthy
children. However, the control group children were
found to have no central nervous system disease ra-
diologically or clinically on follow-up.
The relatively broad age range of 2–27 years is
another limitation. It may raise the question as to
whether age-related hemodynamic changes would af-
fect outcome. To our knowledge, TTP or rCBV
change according to aging in the childhood period has
not been reported. Oyama et al (28) reported that
cerebral blood flow gradually decreases with aging in
moyamoya disease; however, their patient population
ranged from 16 to 58 years. We also could not get
proper data from a healthy population to get standard
hemodynamic features of children. This remains an
unsolved problem in this study, and future investiga-
tion must be performed.
In summary, TTP perfusion maps can depict the
preoperative hemodyamic status of patients with
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moyamoya disease and postoperative changes as well.
We postulate that perfusion MR imaging is a useful
tool to evaluate cerebral blood flow in moyamoya
disease.
Conclusion
Perfusion-weighted MR imaging can be applied for
evaluating the postoperative changes in the cerebral
blood flow in moyamoya disease. A shortening of the
TTP in the MCA territory of the hemisphere oper-
ated on is a marker for the development of collateral
circulation from the ECA to the ICA.
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